SpectraScience
San Diego
About SpectraScience
SpectraScience offers a simplified yet highly effective way of diagnosing colorectal cancer early, when recovery rates are high. Our WavSTAT Optical Biopsy System® uses light to diagnose tissue health. In fact, our patented technology instantly detects if tissue is normal, pre-cancerous or cancerous without the need for a costly physical biopsy. According to the American Cancer Society, over 140,000 new cases of colorectal cancer are expected in the US this year alone. This dreaded disease is the second leading cause of cancer-related deaths in the US (after lung cancer), and the third most common cancer overall. Only 39% of colorectal cancers are detected at an early stage.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $5.9M
- Funding stage: IPO
- Last round: Post-IPO Debt (Jan 2014)
- Ticker: otcpink:SCIE
- Website: spectrascience.com
- Phone: +18588470880
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/spectrascience-2276721 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.